In vivo modelling of patient genetic heterogeneity identifies concurrent Wnt and PI3K activity as a potent driver of invasive cholangiocarcinoma growth (2021)

First Author: Younger N

Attributed to: Delivering Translational Opportunities From Edinburgh (DTOFE) funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.07.05.449722

Publication URI: http://dx.doi.org/10.1101/2021.07.05.449722

Type: Preprint